在怀孕期间使用新辅助化疗治疗宫癌 (IB3) 的病例
Xiaohua Li1, Yu Zhang1, Haiying Wu2
1Obstetrics gynecology, People's Hospital of Hebei province, Shijiazhuang, Hebei, 050000, China.
怀孕早期的宫癌带来了诊断上的挑战,往往模仿威胁堕胎. 一个案例研究强调了成功的新辅助化疗和剖腹产对于这种罕见的并发症.
科学领域:
- 妇科 妇科 妇科 妇科
- 产科 产科 产科 产科 产科
- 在瘤学瘤学.
背景情况:
- 怀孕期间的宫癌是罕见的,并且由于与威胁堕胎的重叠症状而难以诊断.
- 对于患有宫癌的孕妇,缺乏标准化的治疗方案,需要个性化管理计划.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Radiological Investigation I: X-ray and CT
